Analysts expect Chinese Biotechs to break even in over a yea...
Analysts expect Chinese Biotechs to break even in over a year, but could be delayed if growth slows. The firm's current negative equity is a significant issue.
Sinocelltech Group Limited's (SHSE:688520) Profit Outlook
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment